nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0748	0.119	CbGbCtD
Fluvoxamine—CYP3A7—Sorafenib—thyroid cancer	0.0748	0.119	CbGbCtD
Fluvoxamine—CYP2B6—Sorafenib—thyroid cancer	0.0712	0.113	CbGbCtD
Fluvoxamine—CYP3A5—Sorafenib—thyroid cancer	0.0561	0.089	CbGbCtD
Fluvoxamine—CYP2C19—Sorafenib—thyroid cancer	0.0452	0.0718	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—thyroid cancer	0.0432	0.0686	CbGbCtD
Fluvoxamine—CYP1A2—Sorafenib—thyroid cancer	0.0417	0.0663	CbGbCtD
Fluvoxamine—CYP2C9—Sorafenib—thyroid cancer	0.0376	0.0597	CbGbCtD
Fluvoxamine—ABCB1—Sorafenib—thyroid cancer	0.0365	0.0579	CbGbCtD
Fluvoxamine—CYP3A4—Vandetanib—thyroid cancer	0.0363	0.0576	CbGbCtD
Fluvoxamine—CYP2D6—Sorafenib—thyroid cancer	0.0344	0.0546	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—thyroid cancer	0.0222	0.0352	CbGbCtD
Fluvoxamine—CYP3A4—Sorafenib—thyroid cancer	0.0219	0.0347	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—thyroid cancer	0.0209	0.0331	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—thyroid cancer	0.0133	0.0211	CbGbCtD
Fluvoxamine—Affect lability—Doxorubicin—thyroid cancer	0.000275	0.000744	CcSEcCtD
Fluvoxamine—Hypokalaemia—Epirubicin—thyroid cancer	0.000275	0.000744	CcSEcCtD
Fluvoxamine—Diarrhoea—Sorafenib—thyroid cancer	0.000275	0.000744	CcSEcCtD
Fluvoxamine—Breast disorder—Epirubicin—thyroid cancer	0.000273	0.000738	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000272	0.000736	CcSEcCtD
Fluvoxamine—Face oedema—Doxorubicin—thyroid cancer	0.00027	0.00073	CcSEcCtD
Fluvoxamine—Gastritis—Epirubicin—thyroid cancer	0.000268	0.000723	CcSEcCtD
Fluvoxamine—Muscular weakness—Epirubicin—thyroid cancer	0.000267	0.000721	CcSEcCtD
Fluvoxamine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000266	0.000719	CcSEcCtD
Fluvoxamine—Dizziness—Sorafenib—thyroid cancer	0.000266	0.000719	CcSEcCtD
Fluvoxamine—Mood swings—Doxorubicin—thyroid cancer	0.000265	0.000716	CcSEcCtD
Fluvoxamine—Abdominal distension—Epirubicin—thyroid cancer	0.000263	0.000711	CcSEcCtD
Fluvoxamine—Ataxia—Doxorubicin—thyroid cancer	0.000263	0.000711	CcSEcCtD
Fluvoxamine—Dysphagia—Epirubicin—thyroid cancer	0.000261	0.000706	CcSEcCtD
Fluvoxamine—Asthma—Epirubicin—thyroid cancer	0.000261	0.000706	CcSEcCtD
Fluvoxamine—Influenza—Epirubicin—thyroid cancer	0.000261	0.000706	CcSEcCtD
Fluvoxamine—Dehydration—Doxorubicin—thyroid cancer	0.00026	0.000703	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000258	0.000698	CcSEcCtD
Fluvoxamine—Dry skin—Doxorubicin—thyroid cancer	0.000256	0.000693	CcSEcCtD
Fluvoxamine—Pancreatitis—Epirubicin—thyroid cancer	0.000256	0.000692	CcSEcCtD
Fluvoxamine—Vomiting—Sorafenib—thyroid cancer	0.000256	0.000691	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000256	0.000691	CcSEcCtD
Fluvoxamine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000255	0.000688	CcSEcCtD
Fluvoxamine—Angina pectoris—Epirubicin—thyroid cancer	0.000255	0.000688	CcSEcCtD
Fluvoxamine—Rash—Sorafenib—thyroid cancer	0.000254	0.000685	CcSEcCtD
Fluvoxamine—Dermatitis—Sorafenib—thyroid cancer	0.000253	0.000685	CcSEcCtD
Fluvoxamine—Breast disorder—Doxorubicin—thyroid cancer	0.000253	0.000683	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000252	0.000681	CcSEcCtD
Fluvoxamine—Headache—Sorafenib—thyroid cancer	0.000252	0.000681	CcSEcCtD
Fluvoxamine—Bronchitis—Epirubicin—thyroid cancer	0.000251	0.000679	CcSEcCtD
Fluvoxamine—Gastritis—Doxorubicin—thyroid cancer	0.000248	0.000669	CcSEcCtD
Fluvoxamine—Muscular weakness—Doxorubicin—thyroid cancer	0.000247	0.000667	CcSEcCtD
Fluvoxamine—Dysuria—Epirubicin—thyroid cancer	0.000244	0.00066	CcSEcCtD
Fluvoxamine—Abdominal distension—Doxorubicin—thyroid cancer	0.000243	0.000658	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000243	0.000656	CcSEcCtD
Fluvoxamine—Asthma—Doxorubicin—thyroid cancer	0.000242	0.000654	CcSEcCtD
Fluvoxamine—Influenza—Doxorubicin—thyroid cancer	0.000242	0.000654	CcSEcCtD
Fluvoxamine—Dysphagia—Doxorubicin—thyroid cancer	0.000242	0.000654	CcSEcCtD
Fluvoxamine—Pollakiuria—Epirubicin—thyroid cancer	0.000241	0.000652	CcSEcCtD
Fluvoxamine—Nausea—Sorafenib—thyroid cancer	0.000239	0.000646	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000239	0.000645	CcSEcCtD
Fluvoxamine—Weight increased—Epirubicin—thyroid cancer	0.000238	0.000643	CcSEcCtD
Fluvoxamine—Pancreatitis—Doxorubicin—thyroid cancer	0.000237	0.000641	CcSEcCtD
Fluvoxamine—Weight decreased—Epirubicin—thyroid cancer	0.000236	0.000639	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000236	0.000637	CcSEcCtD
Fluvoxamine—Angina pectoris—Doxorubicin—thyroid cancer	0.000236	0.000637	CcSEcCtD
Fluvoxamine—Pneumonia—Epirubicin—thyroid cancer	0.000234	0.000633	CcSEcCtD
Fluvoxamine—Drowsiness—Epirubicin—thyroid cancer	0.000233	0.00063	CcSEcCtD
Fluvoxamine—Bronchitis—Doxorubicin—thyroid cancer	0.000233	0.000629	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000231	0.000624	CcSEcCtD
Fluvoxamine—Renal failure—Epirubicin—thyroid cancer	0.000229	0.000619	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000228	0.000617	CcSEcCtD
Fluvoxamine—Stomatitis—Epirubicin—thyroid cancer	0.000227	0.000614	CcSEcCtD
Fluvoxamine—Jaundice—Epirubicin—thyroid cancer	0.000227	0.000614	CcSEcCtD
Fluvoxamine—Conjunctivitis—Epirubicin—thyroid cancer	0.000227	0.000612	CcSEcCtD
Fluvoxamine—Urinary tract infection—Epirubicin—thyroid cancer	0.000227	0.000612	CcSEcCtD
Fluvoxamine—Dysuria—Doxorubicin—thyroid cancer	0.000226	0.000611	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000225	0.000607	CcSEcCtD
Fluvoxamine—Sweating—Epirubicin—thyroid cancer	0.000223	0.000604	CcSEcCtD
Fluvoxamine—Pollakiuria—Doxorubicin—thyroid cancer	0.000223	0.000604	CcSEcCtD
Fluvoxamine—Haematuria—Epirubicin—thyroid cancer	0.000222	0.0006	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000221	0.000597	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00022	0.000596	CcSEcCtD
Fluvoxamine—Weight increased—Doxorubicin—thyroid cancer	0.00022	0.000595	CcSEcCtD
Fluvoxamine—Epistaxis—Epirubicin—thyroid cancer	0.00022	0.000594	CcSEcCtD
Fluvoxamine—Weight decreased—Doxorubicin—thyroid cancer	0.000219	0.000591	CcSEcCtD
Fluvoxamine—Sinusitis—Epirubicin—thyroid cancer	0.000219	0.000591	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000218	0.00059	CcSEcCtD
Fluvoxamine—Agranulocytosis—Epirubicin—thyroid cancer	0.000217	0.000588	CcSEcCtD
Fluvoxamine—Pneumonia—Doxorubicin—thyroid cancer	0.000217	0.000586	CcSEcCtD
Fluvoxamine—Drowsiness—Doxorubicin—thyroid cancer	0.000216	0.000583	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000214	0.000578	CcSEcCtD
Fluvoxamine—Bradycardia—Epirubicin—thyroid cancer	0.000213	0.000576	CcSEcCtD
Fluvoxamine—Renal failure—Doxorubicin—thyroid cancer	0.000212	0.000573	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000211	0.000571	CcSEcCtD
Fluvoxamine—Haemoglobin—Epirubicin—thyroid cancer	0.00021	0.000568	CcSEcCtD
Fluvoxamine—Jaundice—Doxorubicin—thyroid cancer	0.00021	0.000568	CcSEcCtD
Fluvoxamine—Stomatitis—Doxorubicin—thyroid cancer	0.00021	0.000568	CcSEcCtD
Fluvoxamine—Rhinitis—Epirubicin—thyroid cancer	0.00021	0.000567	CcSEcCtD
Fluvoxamine—Conjunctivitis—Doxorubicin—thyroid cancer	0.00021	0.000566	CcSEcCtD
Fluvoxamine—Urinary tract infection—Doxorubicin—thyroid cancer	0.00021	0.000566	CcSEcCtD
Fluvoxamine—Hepatitis—Epirubicin—thyroid cancer	0.000209	0.000565	CcSEcCtD
Fluvoxamine—Haemorrhage—Epirubicin—thyroid cancer	0.000209	0.000565	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000208	0.000563	CcSEcCtD
Fluvoxamine—Pharyngitis—Epirubicin—thyroid cancer	0.000208	0.000561	CcSEcCtD
Fluvoxamine—Sweating—Doxorubicin—thyroid cancer	0.000207	0.000559	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000207	0.000558	CcSEcCtD
Fluvoxamine—Oedema peripheral—Epirubicin—thyroid cancer	0.000206	0.000557	CcSEcCtD
Fluvoxamine—Haematuria—Doxorubicin—thyroid cancer	0.000206	0.000556	CcSEcCtD
Fluvoxamine—Urethral disorder—Epirubicin—thyroid cancer	0.000205	0.000554	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000204	0.000551	CcSEcCtD
Fluvoxamine—Epistaxis—Doxorubicin—thyroid cancer	0.000203	0.00055	CcSEcCtD
Fluvoxamine—Sinusitis—Doxorubicin—thyroid cancer	0.000202	0.000547	CcSEcCtD
Fluvoxamine—Visual impairment—Epirubicin—thyroid cancer	0.000202	0.000545	CcSEcCtD
Fluvoxamine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000201	0.000544	CcSEcCtD
Fluvoxamine—Erythema multiforme—Epirubicin—thyroid cancer	0.000198	0.000535	CcSEcCtD
Fluvoxamine—Bradycardia—Doxorubicin—thyroid cancer	0.000197	0.000533	CcSEcCtD
Fluvoxamine—Eye disorder—Epirubicin—thyroid cancer	0.000195	0.000528	CcSEcCtD
Fluvoxamine—Tinnitus—Epirubicin—thyroid cancer	0.000195	0.000527	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—thyroid cancer	0.000195	0.000526	CcSEcCtD
Fluvoxamine—Cardiac disorder—Epirubicin—thyroid cancer	0.000194	0.000525	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—thyroid cancer	0.000194	0.000524	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—thyroid cancer	0.000194	0.000523	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—thyroid cancer	0.000194	0.000523	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000193	0.00052	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—thyroid cancer	0.000192	0.000519	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000191	0.000517	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000191	0.000515	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—thyroid cancer	0.00019	0.000513	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—thyroid cancer	0.00019	0.000513	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—thyroid cancer	0.000188	0.000507	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—thyroid cancer	0.000187	0.000505	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—thyroid cancer	0.000187	0.000504	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—thyroid cancer	0.000185	0.0005	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—thyroid cancer	0.000183	0.000495	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000183	0.000495	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—thyroid cancer	0.000182	0.000492	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—thyroid cancer	0.000181	0.000489	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—thyroid cancer	0.00018	0.000488	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—thyroid cancer	0.00018	0.000485	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—thyroid cancer	0.000179	0.000485	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—thyroid cancer	0.000179	0.000483	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—thyroid cancer	0.000178	0.000482	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—thyroid cancer	0.000177	0.000478	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—thyroid cancer	0.000176	0.000476	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—thyroid cancer	0.000176	0.000475	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—thyroid cancer	0.000175	0.000473	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—thyroid cancer	0.000174	0.000469	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—thyroid cancer	0.000173	0.000467	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—thyroid cancer	0.000172	0.000464	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—thyroid cancer	0.000171	0.000462	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—thyroid cancer	0.00017	0.000458	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000169	0.000457	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—thyroid cancer	0.000168	0.000455	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—thyroid cancer	0.000168	0.000455	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—thyroid cancer	0.000167	0.000452	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—thyroid cancer	0.000166	0.000449	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—thyroid cancer	0.000165	0.000447	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—thyroid cancer	0.000165	0.000446	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—thyroid cancer	0.000164	0.000444	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—thyroid cancer	0.000164	0.000442	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—thyroid cancer	0.000164	0.000442	CcSEcCtD
Fluvoxamine—Syncope—Epirubicin—thyroid cancer	0.000163	0.000441	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—thyroid cancer	0.000163	0.000441	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—thyroid cancer	0.000163	0.00044	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—thyroid cancer	0.000162	0.000438	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—thyroid cancer	0.000161	0.000435	CcSEcCtD
Fluvoxamine—Loss of consciousness—Epirubicin—thyroid cancer	0.00016	0.000433	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—thyroid cancer	0.000159	0.000429	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—thyroid cancer	0.000159	0.000429	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—thyroid cancer	0.000158	0.000426	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—thyroid cancer	0.000157	0.000425	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000156	0.000423	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—thyroid cancer	0.000156	0.000421	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—thyroid cancer	0.000155	0.000419	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—thyroid cancer	0.000155	0.000419	CcSEcCtD
Fluvoxamine—Arthralgia—Epirubicin—thyroid cancer	0.000155	0.000419	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—thyroid cancer	0.000155	0.000418	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—thyroid cancer	0.000154	0.000418	CcSEcCtD
Fluvoxamine—Discomfort—Epirubicin—thyroid cancer	0.000153	0.000414	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—thyroid cancer	0.000152	0.000411	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—thyroid cancer	0.000152	0.00041	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—thyroid cancer	0.000151	0.000409	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—thyroid cancer	0.000151	0.000408	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—thyroid cancer	0.000151	0.000408	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—thyroid cancer	0.00015	0.000405	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—thyroid cancer	0.000149	0.000402	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—thyroid cancer	0.000149	0.000402	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000149	0.000402	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000148	0.0004	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—thyroid cancer	0.000148	0.000399	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—thyroid cancer	0.000147	0.000397	CcSEcCtD
Fluvoxamine—Shock—Epirubicin—thyroid cancer	0.000146	0.000395	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—thyroid cancer	0.000146	0.000395	CcSEcCtD
Fluvoxamine—Nervous system disorder—Epirubicin—thyroid cancer	0.000146	0.000394	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000146	0.000393	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—thyroid cancer	0.000145	0.000393	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—thyroid cancer	0.000145	0.000392	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000144	0.000388	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—thyroid cancer	0.000143	0.000388	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—thyroid cancer	0.000143	0.000388	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—thyroid cancer	0.000143	0.000388	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—thyroid cancer	0.000143	0.000386	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—thyroid cancer	0.000142	0.000383	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—thyroid cancer	0.000142	0.000383	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—thyroid cancer	0.00014	0.000379	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—thyroid cancer	0.000139	0.000375	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—thyroid cancer	0.000139	0.000375	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—thyroid cancer	0.000138	0.000372	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000138	0.000372	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—thyroid cancer	0.000137	0.000369	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000135	0.000366	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—thyroid cancer	0.000135	0.000366	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000135	0.000364	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000135	0.000364	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—thyroid cancer	0.000134	0.000363	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—thyroid cancer	0.000134	0.000363	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—thyroid cancer	0.000133	0.000361	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000133	0.000359	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—thyroid cancer	0.000133	0.000358	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—thyroid cancer	0.000132	0.000357	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—thyroid cancer	0.000131	0.000354	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—thyroid cancer	0.000131	0.000354	CcSEcCtD
Fluvoxamine—Decreased appetite—Epirubicin—thyroid cancer	0.000129	0.000349	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—thyroid cancer	0.000128	0.000347	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000128	0.000347	CcSEcCtD
Fluvoxamine—Fatigue—Epirubicin—thyroid cancer	0.000128	0.000346	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—thyroid cancer	0.000127	0.000343	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—thyroid cancer	0.000127	0.000343	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000125	0.000339	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—thyroid cancer	0.000124	0.000336	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—thyroid cancer	0.000123	0.000334	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—thyroid cancer	0.000123	0.000331	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—thyroid cancer	0.000122	0.000331	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—thyroid cancer	0.000122	0.00033	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000122	0.000328	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—thyroid cancer	0.000121	0.000327	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—thyroid cancer	0.00012	0.000323	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000119	0.000321	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—thyroid cancer	0.000119	0.00032	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—thyroid cancer	0.000118	0.000319	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—thyroid cancer	0.000118	0.000318	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—thyroid cancer	0.000118	0.000318	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—thyroid cancer	0.000117	0.000318	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—thyroid cancer	0.000117	0.000318	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000113	0.000306	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000112	0.000304	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—thyroid cancer	0.000109	0.000296	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—thyroid cancer	0.000109	0.000295	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—thyroid cancer	0.000109	0.000294	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—thyroid cancer	0.000109	0.000294	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—thyroid cancer	0.000107	0.000288	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—thyroid cancer	0.000105	0.000284	CcSEcCtD
Fluvoxamine—Diarrhoea—Epirubicin—thyroid cancer	0.000102	0.000275	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000101	0.000274	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—thyroid cancer	9.87e-05	0.000267	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—thyroid cancer	9.83e-05	0.000266	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—thyroid cancer	9.73e-05	0.000263	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—thyroid cancer	9.45e-05	0.000255	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—thyroid cancer	9.41e-05	0.000254	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—thyroid cancer	9.37e-05	0.000253	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—thyroid cancer	9.36e-05	0.000253	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—thyroid cancer	9.31e-05	0.000252	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—thyroid cancer	9.09e-05	0.000246	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—thyroid cancer	8.83e-05	0.000239	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—thyroid cancer	8.74e-05	0.000236	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—thyroid cancer	8.67e-05	0.000234	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—thyroid cancer	8.66e-05	0.000234	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—thyroid cancer	8.61e-05	0.000233	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—thyroid cancer	8.17e-05	0.000221	CcSEcCtD
